(Sharecast News) - Avacta Therapeutics announced the appointment of Francis Wilson as its chief scientific officer on Monday, effective immediately, as the AIM-traded clinical-stage biopharmaceutical company prepared for further development of its 'preCISION' tumour-activated oncology delivery platform.
Wilson joined Avacta in September 2022 as vice-president of chemistry and had reportedly played...

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE